Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AJUL
4376
Innovator Equity Defined Protection ETF - 2 Yr to July 2028
AJUL
$98.5M
| $150K | ﹤0.01% |
5,145
-42
| -0.8% | -$1.21K |
2024 Q4
4 quarters
|
|
4377
FT Vest US Equity Buffer ETF September
FSEP
$1.39B
| $149K | ﹤0.01% |
+2,897
| New | +$148K |
2025 Q4
0 quarters
|
|
4378
AllianzIM U.S. Equity Buffer10 Apr ETF
APRT
$47.1M
| $149K | ﹤0.01% |
3,581
-343
| -9% | -$14.1K |
2025 Q1
3 quarters
|
|
|
GRP.U
4379
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $149K | ﹤0.01% |
2,518
+84
| +3% | +$4.71K |
2022 Q4
12 quarters
|
|
4380
American Outdoor Brands
AOUT
$206M
| $149K | ﹤0.01% |
19,271
+1,902
| +11% | +$14.1K |
2024 Q3
5 quarters
|
|
4381
Rackspace Technology
RXT
$1.05B
| $149K | ﹤0.01% |
153,348
+13,127
| +9% | +$16.5K |
2022 Q1
15 quarters
|
|
4382
Innovator Equity Defined Protection ETF - 2 Yr to April 2028
AAPR
$70.8M
| $149K | ﹤0.01% |
5,239
-55
| -1% | -$1.55K |
2024 Q3
5 quarters
|
|
4383
Liberty Global Class C
LBTYK
$2.98B
| $148K | ﹤0.01% |
13,451
-4,524
| -25% | -$50.3K |
2013 Q4
48 quarters
|
|
|
FEBM
4384
FT Vest U.S. Equity Max Buffer ETF - February
FEBM
$46.1M
| $148K | ﹤0.01% |
4,884
+343
| +8% | +$10.3K |
2025 Q2
2 quarters
|
|
4385
Alta Equipment Group
ALTG
$212M
| $148K | ﹤0.01% |
32,228
+3,015
| +10% | +$16.6K |
2022 Q1
15 quarters
|
|
|
SVM
4386
Silvercorp Metals
SVM
$2.34B
| $148K | ﹤0.01% |
17,720
+11,732
| +196% | +$85.2K |
2022 Q3
13 quarters
|
|
4387
AllianzIM U.S. Equity Buffer20 Jun ETF
JUNW
$382M
| $148K | ﹤0.01% |
4,426
-88
| -2% | -$2.91K |
2025 Q1
3 quarters
|
|
|
AIRJ
4388
Montana Technologies Corp
AIRJ
$288M
| $148K | ﹤0.01% |
37,506
+3,760
| +11% | +$16.2K |
2025 Q2
2 quarters
|
|
4389
AllianzIM U.S. Equity Buffer10 Mar ETF
MART
$29.2M
| $148K | ﹤0.01% |
3,812
-118
| -3% | -$4.49K |
2025 Q1
3 quarters
|
|
4390
AllianzIM U.S. Equity Buffer10 May ETF
MAYT
$239M
| $147K | ﹤0.01% |
3,988
-111
| -3% | -$4.04K |
2025 Q1
3 quarters
|
|
4391
AllianzIM U.S. Equity Buffer20 Mar ETF
MARW
$85.9M
| $147K | ﹤0.01% |
4,288
-324
| -7% | -$11K |
2025 Q2
2 quarters
|
|
4392
Sanara MedTech
SMTI
$320M
| $147K | ﹤0.01% |
6,306
-1,444
| -19% | -$37.3K |
2023 Q2
10 quarters
|
|
4393
Innovator US Equity Accelerated Plus ETF April
XTAP
$18.8M
| $146K | ﹤0.01% |
3,598
-144
| -4% | -$5.76K |
2024 Q3
5 quarters
|
|
4394
AllianzIM U.S. Equity Buffer10 Jun ETF
JUNT
$118M
| $146K | ﹤0.01% |
4,013
-160
| -4% | -$5.74K |
2025 Q1
3 quarters
|
|
|
AGEN
4395
Agenus
AGEN
$378M
| $145K | ﹤0.01% |
46,273
+36,053
| +353% | +$144K |
2014 Q2
46 quarters
|
|
4396
ATS Corp
ATS
$1.79B
| $145K | ﹤0.01% |
5,264
+756
| +17% | +$20.2K |
2024 Q3
5 quarters
|
|
4397
Exagen
XGN
$198M
| $143K | ﹤0.01% |
23,601
+15,965
| +209% | +$145K |
2022 Q1
15 quarters
|
|
|
JULM
4398
FT Vest U.S. Equity Max Buffer ETF - July
JULM
$34.1M
| $143K | ﹤0.01% |
4,266
+657
| +18% | +$21.9K |
2025 Q3
1 quarter
|
|
4399
1-800-Flowers.com
FLWS
$164M
| $143K | ﹤0.01% |
36,342
+5,500
| +18% | +$21.6K |
2016 Q2
38 quarters
|
|
|
ACB
4400
Aurora Cannabis
ACB
$248M
| $142K | ﹤0.01% |
33,709
+16,292
| +94% | +$79.7K |
2022 Q1
15 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.